IL1B and diabetes mellitus: As seen in TB patients, high cortisol doses inhibited proliferative capacity and production of TNF-α, IL-1β, IL-2, IFN-γ, and IL-10, in TB+DM and DM patients as well as Co. Although TB+DM continued to show a remarkable response despite this steroid treatment.